Can Patients with Oligoasthenoteratozoospermia Undergo IVF? An Analysis of Second-Generation IVF Technology
Starting with a real case of a 38-year-old patient with severe oligoasthenoteratozoospermia who successfully achieved parenthood through ICSI, this article systematically covers: the definition and diagnostic criteria of oligoasthenoteratozoospermia, the principle of second-generation IVF (ICSI) technology and its differences from conventional IVF, the indications and success rates of ICSI, a comparative overview of ICSI services and costs at major reproductive medicine centers in Hong Kong, the complete treatment process, and practical advice for patients. The entire article revolves around the central theme of male infertility patients realizing their dream of parenthood through ICSI technology, providing clear decision-making references and action guides.
1. What Is Oligoasthenoteratozoospermia?
Oligoasthenoteratozoospermia is a comprehensive condition encompassing three abnormalities:
Oligozoospermia (low sperm count): According to WHO standards, sperm concentration should be no less than 15 million/mL.
Asthenozoospermia (poor sperm motility): Progressive motility should be no less than 32%.
Teratozoospermia (abnormal sperm morphology): Normal morphology should be no less than 4%.
When all three parameters fall severely below normal ranges, the condition is classified as severe oligoasthenoteratozoospermia. In such cases, natural conception is virtually impossible, as sperm lack the quantity and motility to penetrate the egg's outer layer.
2. What Is Second-Generation IVF (ICSI)?
Second-generation IVF is medically known as Intracytoplasmic Sperm Injection (ICSI) .
To understand ICSI, it helps to compare it with conventional IVF:
First-generation IVF (conventional IVF): Like "free love." Sperm and eggs are placed together in a culture dish, and sperm must swim and penetrate the egg on their own. This requires adequate sperm quantity and motility.
Second-generation IVF (ICSI): Like an "arranged marriage." An embryologist selects the best-looking and most motile single sperm under a microscope and injects it directly into the egg's cytoplasm using a micro-injection needle.
The core advantage of ICSI is that it dramatically lowers the sperm quantity requirement — conventional IVF requires tens of thousands of motile sperm, while ICSI theoretically requires only one viable sperm to achieve fertilization. For patients with severe oligoasthenoteratozoospermia, ICSI is currently the most effective assisted reproduction option.
In Hong Kong, ICSI is widely available at major reproductive medicine centers. Reproductive medicine specialist Dr. Yung Shu-fei explains that ICSI involves an embryologist placing a single high-quality sperm directly into the egg — known colloquially as second-generation IVF — and is particularly suitable for cases with poor sperm quality.
3. Who Is Suitable for ICSI?
In Hong Kong, ICSI is generally recommended for the following conditions:
Severe oligoasthenoteratozoospermia: extremely low sperm count, poor motility, or abnormal morphology
Obstructive azoospermia: blocked vas deferens but normal sperm production; sperm can be retrieved via PESA/TESA
Non-obstructive azoospermia: sperm can be retrieved via micro-TESE in approximately 30%-50% of patients
Couples with previous low fertilization rates or failed fertilization with conventional IVF
For patients with sperm concentration below 1 million/mL or progressive motility below 1%, ICSI is the only viable fertility option.
4. What Is the Success Rate of ICSI?
The fertilization rate with ICSI typically ranges from 65% to 80%. Overall, the single-cycle clinical pregnancy rate is approximately 40% to 60%.
Success rates are influenced by multiple factors:
Female partner's age: younger women have higher success rates
Sperm DNA fragmentation index: even if fertilization succeeds, high DNA fragmentation can lead to embryo arrest or miscarriage
Good news for patients with severe teratozoospermia: as long as the sperm's DNA is healthy, "abnormal appearance" alone does not determine success. Embryologists use high-magnification microscopy to select sperm with the most normal morphology for injection.
5. Major Reproductive Medicine Centers in Hong Kong Offering ICSI
Hong Kong has over 20 licensed assisted reproduction service providers, most of which offer ICSI.
1. Hong Kong Sanatorium & Hospital (HKSH) IVF Centre
Established in 1986, it is one of Hong Kong's oldest IVF centers. HKSH explicitly states: "The advent of ICSI has successfully provided treatment for infertile men, bringing a ray of hope to patients with insufficient sperm". Sperm can be retrieved directly from testicular tissue (TESE) or from the epididymis (MESA). Costs approximately HKD 120,000–170,000, with success rates around 45%–55%.
2. CUHK Fertility Centre, Prince of Wales Hospital
Established in 1984 by Prince of Wales Hospital and the Department of Obstetrics and Gynaecology at the Chinese University of Hong Kong. It is the first assisted reproduction center in Hong Kong to receive ISO 9001 certification. Offers IVF and ICSI services. Public patient costs are low (approximately HKD 10,000–24,500) but waiting times can reach 18 months; private patient costs are approximately HKD 65,000–73,000. Clinical pregnancy rates for patients under 35 reach 68%.
3. Union Hospital Reproductive Medicine Centre
Established in October 2000, it was the first private hospital in the New Territories and Kowloon to offer assisted reproduction services. Offers ICSI services. Success rates range from 55% to 65%, with costs approximately HKD 80,000–200,000.
4. Heal Fertility Centre
Offers advanced ICSI services with personalized treatment plans tailored by specialists, embryologists, and nursing teams.
6. The ICSI Treatment Process
The complete ICSI treatment process is as follows:
Step 1: Pre-treatment assessment
Male: semen analysis and basic infectious disease screening; if sperm count is extremely low, further testing or surgical sperm retrieval may be recommended
Female: blood tests and vaginal ultrasound at the start of menstruation to assess ovarian status
Step 2: Ovarian stimulation and egg retrieval
The female partner receives ovulation-inducing medication to promote development of multiple follicles, followed by egg retrieval surgery.
Step 3: Sperm collection and ICSI injection
Embryologists select a single sperm with normal morphology and good motility from the male partner's semen sample and inject it directly into the egg's cytoplasm using a micro-injection needle.
Step 4: Embryo culture and assessment
After fertilization, embryos are cultured in the laboratory and monitored for development.
Step 5: Embryo transfer
When embryos reach the ideal developmental stage (typically day 5–6 blastocyst), the best-quality embryo is selected for transfer into the female partner's uterus. Excess healthy embryos may be cryopreserved.
7. Cost Overview
ICSI/second-generation IVF costs in Hong Kong vary significantly by hospital type and individual circumstances:
| Hospital Type | Cost Range (HKD) | Notes |
|---|---|---|
| Public hospitals (Prince of Wales, etc.) | 10,000–73,000 | Long public waiting times (18 months); shorter for private patients |
| Private hospitals (HKSH, Union, etc.) | 80,000–200,000 | Short appointment lead times, personalized services |
Pre-treatment workup: approximately HKD 10,000–20,000
Ovulation induction medications: approximately HKD 20,000–50,000
Egg retrieval and ICSI: approximately HKD 15,000–30,000
Embryo culture: approximately HKD 10,000–20,000
Embryo transfer: approximately HKD 8,000–15,000
Embryo cryopreservation: approximately HKD 10,000–15,000 for the first year
8. Practical Advice for Patients with Oligoasthenoteratozoospermia
1. Get tested early and obtain a clear diagnosis. If you have been trying to conceive for over a year without success (or 6 months if the female partner is over 35), men should undergo semen analysis as soon as possible.
2. Improve lifestyle habits. Quit smoking and alcohol, maintain regular sleep schedules, avoid prolonged sitting and high-temperature environments (saunas, hot baths) — these can help improve sperm quality. Antioxidant therapy (vitamin E, coenzyme Q10, etc.) can help reduce DNA fragmentation.
3. Choose an experienced reproductive center. ICSI success rates are highly dependent on laboratory conditions and embryologist skill — choosing an experienced team is critical.
4. Maintain realistic expectations about success rates. While ICSI solves the fertilization problem, it does not guarantee 100% success. Approximately 1%–3% of patients may still experience complete fertilization failure even with ICSI. If needed, advanced techniques such as IMSI (high-magnification sperm selection) or AOA (assisted oocyte activation) may be considered.
5. Be mentally prepared. Treatment for severe oligoasthenoteratozoospermia may require multiple cycles — patience and persistence are essential.
Patients with oligoasthenoteratozoospermia can realize their dream of parenthood through second-generation IVF (ICSI). The specific treatment plan should be based on a comprehensive assessment of sperm quality, female partner conditions, and other factors. If you are facing infertility related to oligoasthenoteratozoospermia, please feel free to contact us. We will provide professional consultation and information support tailored to your situation.
0 comments